Angion Biomedica Corp (ANGN) Social Stream
ANGION BIOMEDICA CORP (ANGN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ANGION BIOMEDICA CORP.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-15 | 4 | $50 | $15 | $26.666 | $1 | 2566.6% |
2022-03-30 | 3 | $50 | $5 | $21 | $1 | 2000% |
2022-04-01 | 4 | $50 | $5 | $21 | $1 | 2000% |
2022-05-16 | 4 | $32 | $5 | $15 | $1 | 1400% |
2022-05-23 | 4 | $28 | $5 | $13.666 | $1 | 1266.6% |
2022-06-30 | 4 | $1.5 | $1.5 | $1.5 | $1 | 50% |
2022-08-15 | 3 | $1.5 | $1.5 | $1.5 | $1 | 50% |
NA | 2 | $NA | $NA | $NA | $1 | NA% |
The Trend in the Analyst Price Target
Over the past 35 weeks, ANGN's average price target has gone down $19.5.
ANGN reports an average of 35.8% for its upside potential over the past 46 days.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-06-30 | 3 | 1.5 | 1.5 | 1.5 | 1.14 | 31.58% |
2022-06-30 | 4 | 1.5 | 1.5 | 1.5 | 1.14 | 31.58% |
2022-08-15 | 3 | 1.5 | 1.5 | 1.5 | 1.04 | 44.23% |
ANGN Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 3 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
ANGN's average broker recommendation rating worsened by 2 over the prior 153 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ANGION BIOMEDICA CORP fares relative to all US stocks, note that its variance in analysts' estimates is lower than -386.03% of that group.
- In the context of all US stocks, ANGION BIOMEDICA CORP's number of analysts covering the stock is greater than 95.71% of them.
- In terms of how ANGION BIOMEDICA CORP fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 546.6% of that group.
- In terms of how ANGION BIOMEDICA CORP fares relative to Healthcare stocks, note that its average analyst price target is greater than 174.74% of that group.
In the Pharmaceutical Products industry, BOLT, TERN, and ADAG are the three stocks most similar to ANGION BIOMEDICA CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ANGN using the data that counts. Try POWR Ratings for free.